𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

✍ Scribed by Dr Philippe Gajdos; Sylvie Chevret; Bernard Clair; Christine Tranchant; Claude Chastang


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
686 KB
Volume
41
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Randomized, controlled trial of intraven
✍ Gil I. Wolfe; Richard J. Barohn; Barbara M. Foster; Carlayne E. Jackson; John T. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract We initiated a randomized, double‐blinded, placebo‐controlled trial of intravenous immunoglobulin (IVIG) treatment in myasthenia gravis (MG). Patients received IVIG 2 gm/kg at induction and 1 gm/kg after 3 weeks vs. 5% albumin placebo. The primary efficacy measurement was the change in

Pharmacokinetic modeling of plasma and c
✍ E. Chatelut; H. Roche; Y. Plusquellec; F. Peyrille; J. De Biasi; A. Pujol; P. Ca πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 436 KB

A pharmacokinetic study was performed in plasma and cerebrospinal fluid (CSF) of patients suffering from brain tumors to describe the disposition of methotrexate. An open three-compartment model was developed to fit together the data obtained in plasma and CSF. The pharmacokinetic parameters obtaine

Effect of high-dose intravenous immunogl
✍ Boyd M. Koffman; Marinos C. Dalakas πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 2 views

The effect of intravenous immunoglobulin (IVIG) on various laboratory values was measured immediately before and after completion of serial monthly infusions of IVIG (2 g/kg) or an equal volume of placebo over 3-12 months, in 46 patients with neuromuscular diseases participating in controlled trials

Randomized controlled trial of standard
✍ W. H. Chan; L. W. Khin; Y. F. A. Chung; Y. C. Goh; H. S. Ong; W. K. Wong πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## Background Rebleeding from peptic ulcers is a major contributor to death. This study compared standard (40-mg intravenous infusion of omeprazole once daily for 3 days) and high-dose (80-mg bolus of omeprazole followed by 8-mg/h infusion for 72 h) in reducing the rebleeding rate (pri